MGP and type 2 diabetes mellitus: The effect of T2DM on warfarin dose hasn’t been extensively investigated yet, and concerns remain that warfarin may be less favorable than direct oral anticoagulants (DOACs) for patients with diabetes and AF due to increased risks of calcification in coronary and renal artery resulting from reduced matrix Gla protein [60,61].